
High-Flow Nasal Oxygen Improves Safe Apnea Time in Morbidly Obese Patients Undergoing General Anesthesia: A Randomized Controlled Trial
Author(s) -
David T. Wong,
Amélie Dallaire,
Kawal Preet Singh,
Poorna Madhusudan,
Timothy Jackson,
Mandeep Singh,
Jean Wong,
Frances Chung
Publication year - 2019
Publication title -
anesthesia and analgesia/anesthesia and analgesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.404
H-Index - 201
eISSN - 1526-7598
pISSN - 0003-2999
DOI - 10.1213/ane.0000000000003966
Subject(s) - medicine , anesthesia , rocuronium , pulse oximetry , apnea , remifentanil , propofol , oxygenation , laryngoscopy , surgery , intubation
Morbidly obese patients undergoing general anesthesia are at risk of hypoxemia during anesthesia induction. High-flow nasal oxygenation use during anesthesia induction prolongs safe apnea time in nonobese surgical patients. The primary objective of our study was to compare safe apnea time, between patients given high-flow nasal oxygenation or conventional facemask oxygenation during anesthesia induction, in morbidly obese surgical patients.